Cover Image
市場調查報告書

全球夜間頻尿市場

Global Market Study on Nocturia: Antispasmodic Drug Type Segment to Exhibit a High Growth Rate During the Forecast Period

出版商 Persistence Market Research 商品編碼 602308
出版日期 內容資訊 英文 192 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球夜間頻尿市場 Global Market Study on Nocturia: Antispasmodic Drug Type Segment to Exhibit a High Growth Rate During the Forecast Period
出版日期: 2017年12月22日 內容資訊: 英文 192 Pages
簡介

本報告提供全球夜間頻尿市場相關調查,市場概要和各市場區隔,各地區趨勢,及加入此市場的主要企業的簡介等彙整資料。

第1章 預測

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 市場規模與預測
  • 市場趨勢
  • 供應鏈
  • 成本結構
  • 各地區主要加入企業的市場地位
  • 產品生命週期分析
  • 經銷商清單
  • 法律規章

第4章 全球市場分析與預測

  • 各適應症
    • 混合夜間頻尿
    • 膀胱低用量
    • 多尿症性夜間頻尿
    • 多尿症
  • 各藥物類型
    • 抗膽鹼促效劑
    • 去氨加壓素
    • 抗生劑
    • 抗痙攣劑
    • 其他
  • 各流通管道
    • 院內藥局
    • 零售藥局
    • 藥妝店
    • 線上藥局

第5章 北美市場

第6章 南美市場

第7章 歐洲市場

第8章 APEJ市場

第9章 中東、非洲市場

第10章 企業佔有率分析,競爭環境,企業簡介

  • 競爭環境
  • 企業簡介
    • Allergan, Inc.
    • Urigen Pharmaceuticals
    • Ferring Pharmaceuticals
    • Glenmark Pharmaceuticals Inc.
    • Teva Pharmaceutical Industries Ltd.
    • AA Pharma Inc.
    • Avadel Pharmaceuticals plc

第11章 調查方法

第12章 免責聲明

圖表

目錄

Introduction:

Nocturia is major problem in most of the population in different regions, as the condition for causing nocturia basically depends on ageing of the patient, incidences of chronic diseases such as diabetes or any other factors. Nocturia affects people of all age groups right from children to old people. In medical science, nocturia is known as excessive urination at night where the body produces more urine during sleep time. Nocturia affects the productivity of people suffering from the condition during working hours as well.

Persistence Market Research uses a unique research methodology which is a strong blend of secondary and in-depth primary research. Extensive primary interviews with key market players, stakeholders, market observers and experts are carried out to collect necessary data and information pertaining to various segments and across key regions. The data crunching and statistical analysis so performed undergoes multiple layers of validation to garner appropriate market insights which could benefit business by impacting critical decisions. The exhaustive research methodology has been applied to thoroughly understand and study the market for nocturia and the findings and insights have been skilfully crafted following a systematic structure in the new report titled "Nocturia Market: Global Industry Analysis (2012-2016) and Forecast (2017-2026)".

Global Nocturia Market: Segmentation:

Market segmentation by indication:

Based on indication, the market has been segmented into:

  • Mixed nocturia
  • Low nocturnal bladder capacity
  • Nocturnal polyuria
  • Global polyuria

Market segmentation by drug type:

Based on drug type, the market has been segmented into:

  • Anticholinergic drugs
  • Desmopressin
  • Antibiotics
  • Antispasmodic
  • Others

Market segmentation by distribution channel:

Based on Distribution Channel, the market has been segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Market Segmentation by region:

Based on region, the market is segmented into:

  • North America
  • Latin America
  • Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa

The global nocturia market research study covers competitive landscape that includes market shares, revenues, growth strategies applied, product portfolio analysis, distribution channels, expansion in several geographies, marketing strategies, SWOT analysis, pricing analysis, etc., of the various key players in the global nocturia market. Such an intelligence framework can be used to gain competitive advantage in the long run, especially helpful for new entrants in the nocturia market.

  • Delivering value based insights backed by pertinent market data
  • In-depth market analysis, with scrutiny across important geographies
  • Weighted market segmentation to have a complete market understanding
  • Historical data, current statistics and a projected view of the market (forecasts) over a period of five years available in a well-structured format
  • Competitive landscape covering analyses on key players
  • Unbiased view of the global market drawing a realistic outline of data projections
  • Strong accurate research from a strategic standpoint to gain strategic advantage
  • Weighted analysis which covers each and every aspect of the global nocturia market

Table of Contents

1. Global Outlook

2. Global Nocturia Market - Executive Summary

3. Global Nocturia Market Overview

  • 3.1. Introduction
    • 3.1.1. Global Nocturia Market Taxonomy
    • 3.1.2. Global Nocturia Market Definition
  • 3.2. Global Nocturia Market Size (US$ Mn) and Forecast, 2012-2026
    • 3.2.1. Global Nocturia Market Y-o-Y Growth
  • 3.3. Global Nocturia Market Dynamics
    • 3.3.1. Drivers
    • 3.3.2. Restraints
    • 3.3.3. Opportunities
    • 3.3.4. Trends
  • 3.4. Supply Chain
  • 3.5. Cost Structure
  • 3.6. Key Participants Market Presence (Intensity Map) By Region
  • 3.7. Product Life Cycle Nocturia Market
  • 3.8. List of Distributors
  • 3.9. Key Regulations
    • 3.9.1. U.S.
    • 3.9.2. Canada
    • 3.9.3. Europe

4. Global Nocturia Market Analysis and Forecast 2012-2026

  • 4.1. Global Nocturia Market Size and Forecast By Indication, 2012-2026
    • 4.1.1. Mixed Nocturia Market Size and Forecast, 2012-2026
      • 4.1.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.1.2. Market Share Comparison, By Region
      • 4.1.1.3. Y-o-Y growth Comparison, By Region
    • 4.1.2. Low Nocturnal Bladder Capacity Market Size and Forecast, 2012-2026
      • 4.1.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.2.2. Market Share Comparison, By Region
      • 4.1.2.3. Y-o-Y growth Comparison, By Region
    • 4.1.3. Nocturnal Polyuria Market Size and Forecast, 2012-2026
      • 4.1.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.3.2. Market Share Comparison, By Region
      • 4.1.3.3. Y-o-Y growth Comparison, By Region
    • 4.1.4. Global Polyuria Market Size and Forecast, 2012-2026
      • 4.1.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.1.4.2. Market Share Comparison, By Region
      • 4.1.4.3. Y-o-Y growth Comparison, By Region
  • 4.2. Global Nocturia Market Size and Forecast By Drug Type, 2012-2026
    • 4.2.1. Anticholinergic Drugs Market Size and Forecast, 2012-2026
      • 4.2.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.1.2. Market Share Comparison, By Region
      • 4.2.1.3. Y-o-Y growth Comparison, By Region
    • 4.2.2. Desmopressin Market Size and Forecast, 2012-2026
      • 4.2.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.2.2. Market Share Comparison, By Region
      • 4.2.2.3. Y-o-Y growth Comparison, By Region
    • 4.2.3. Antibiotics Market Size and Forecast, 2012-2026
      • 4.2.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.3.2. Market Share Comparison, By Region
      • 4.2.3.3. Y-o-Y growth Comparison, By Region
    • 4.2.4. Antispasmodic Market Size and Forecast, 2012-2026
      • 4.2.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.4.2. Market Share Comparison, By Region
      • 4.2.4.3. Y-o-Y growth Comparison, By Region
    • 4.2.5. Other Drugs Market Size and Forecast, 2012-2026
      • 4.2.5.1. Revenue (US$ Mn) Comparison, By Region
      • 4.2.5.2. Market Share Comparison, By Region
      • 4.2.5.3. Y-o-Y growth Comparison, By Region
  • 4.3. Global Nocturia Market Size and Forecast By Distribution Channel, 2012-2026
    • 4.3.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
      • 4.3.1.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.1.2. Market Share Comparison, By Region
      • 4.3.1.3. Y-o-Y growth Comparison, By Region
    • 4.3.2. Retail Pharmacies Market Size and Forecast, 2012-2026
      • 4.3.2.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.2.2. Market Share Comparison, By Region
      • 4.3.2.3. Y-o-Y growth Comparison, By Region
    • 4.3.3. Drug Stores Market Size and Forecast, 2012-2026
      • 4.3.3.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.3.2. Market Share Comparison, By Region
      • 4.3.3.3. Y-o-Y growth Comparison, By Region
    • 4.3.4. Online Pharmacies Market Size and Forecast, 2012-2026
      • 4.3.4.1. Revenue (US$ Mn) Comparison, By Region
      • 4.3.4.2. Market Share Comparison, By Region
      • 4.3.4.3. Y-o-Y growth Comparison, By Region

5. North America Nocturia Market Size and Forecast, 2012-2026

  • 5.1. North America Outlook
  • 5.2. North America Parent Market Outlook
  • 5.3. North America Target Market Outlook
  • 5.4. Revenue (US$ Mn) Comparison, By Country
    • 5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
    • 5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
  • 5.5. Revenue (US$ Mn) Comparison, By Indication
  • 5.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 5.7. Revenue (US$ Mn) Comparison, By Distribution Channel

6. Latin America Nocturia Market Size and Forecast, 2012-2026

  • 6.1. Latin America Outlook
  • 6.2. Latin America Parent Market Outlook
  • 6.3. Latin America Target Market Outlook
  • 6.4. Revenue (US$ Mn) Comparison, By Country
    • 6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
    • 6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
  • 6.5. Revenue (US$ Mn) Comparison, By Indication
  • 6.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 6.7. Revenue (US$ Mn) Comparison, By Distribution Channel

7. Europe Nocturia Market Size and Forecast, 2012-2026

  • 7.1. Europe Outlook
  • 7.2. Europe Parent Market Outlook
  • 7.3. Europe Target Market Outlook
  • 7.4. Revenue (US$ Mn) Comparison, By Country
    • 7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.2. France Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.3. U.K Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.4. Italy Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.5. Spain Market Size and Forecast (US$ Mn), 2012-2026
    • 7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
  • 7.5. Revenue (US$ Mn) Comparison, By Indication
  • 7.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 7.7. Revenue (US$ Mn) Comparison, By Distribution Channel

8. APEJ Nocturia Market Size and Forecast, 2012-2026

  • 8.1. APEJ Outlook
  • 8.2. APEJ Parent Market Outlook
  • 8.3. APEJ Target Market Outlook
  • 8.4. Revenue (US$ Mn) Comparison, By Country
    • 8.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
    • 8.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
    • 8.4.3. Japan Market Size and Forecast (US$ Mn), 2012-2026
    • 8.4.4. ASEAN Market Size and Forecast (US$ Mn), 2012-2026
    • 8.4.5. Australia & New Zealand Market Size and Forecast (US$ Mn), 2012-2026
    • 8.4.6. Rest of Asia Pacific Market Size and Forecast (US$ Mn), 2012-2026
  • 8.5. Revenue (US$ Mn) Comparison, By Indication
  • 8.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 8.7. Revenue (US$ Mn) Comparison, By Distribution Channel

9. MEA Nocturia Market Size and Forecast, 2012-2026

  • 9.1. MEA Outlook
  • 9.2. MEA Parent Market Outlook
  • 9.3. MEA Target Market Outlook
  • 9.4. Revenue (US$ Mn) Comparison, By Country
    • 9.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
    • 9.4.3. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
  • 9.5. Revenue (US$ Mn) Comparison, By Indication
  • 9.6. Revenue (US$ Mn) Comparison, By Drug Type
  • 9.7. Revenue (US$ Mn) Comparison, By Distribution Channel

10. Global Nocturia Market Company Share, Competition Landscape and Company Profiles

  • 10.1. Competition Landscape
  • 10.2. Company Profiles
    • 10.2.1. Allergan, Inc.
    • 10.2.2. Urigen Pharmaceuticals
    • 10.2.3. Ferring Pharmaceuticals
    • 10.2.4. Glenmark Pharmaceuticals Inc.
    • 10.2.5. Teva Pharmaceutical Industries Ltd.
    • 10.2.6. AA Pharma Inc.
    • 10.2.7. Avadel Pharmaceuticals plc

11. Research Methodology

12. Disclaimer

List of Tables

  • TABLE 1: Global Nocturia Market Value (US$ Mn), 2012-2017
  • TABLE 2: Global Nocturia Market Value (US$ Mn), 2018-2026
  • TABLE 3: Global Nocturia Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • TABLE 4: Global Mixed Nocturia Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 5: Global Mixed Nocturia Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 6: Global Mixed Nocturia Segment Market Share, By Region 2012-2017
  • TABLE 7: Global Mixed Nocturia Segment Market Share, By Region 2018-2026
  • TABLE 8: Global Mixed Nocturia Segment Y-o-Y, By Region 2017-2026
  • TABLE 9: Global Low Nocturnal Bladder Capacity Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 10: Global Low Nocturnal Bladder Capacity Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 11: Global Low Nocturnal Bladder Capacity Segment Market Share, By Region 2012-2017
  • TABLE 12: Global Low Nocturnal Bladder Capacity Segment Market Share, By Region 2018-2026
  • TABLE 13: Global Low Nocturnal Bladder Capacity Segment Y-o-Y, By Region 2017-2026
  • TABLE 14: Global Nocturnal Polyuria Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 15: Global Nocturnal Polyuria Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 16: Global Nocturnal Polyuria Segment Market Share, By Region 2012-2017
  • TABLE 17: Global Nocturnal Polyuria Segment Market Share, By Region 2018-2026
  • TABLE 18: Global Nocturnal Polyuria Segment Y-o-Y, By Region 2017-2026
  • TABLE 19: Global Polyuria Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 20: Global Polyuria Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 21: Global Polyuria Segment Market Share, By Region 2012-2017
  • TABLE 22: Global Polyuria Segment Market Share, By Region 2018-2026
  • TABLE 23: Global Polyuria Segment Y-o-Y, By Region 2017-2026
  • TABLE 24: Global Anticholinergic Drugs Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 25: Global Anticholinergic Drugs Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 26: Global Anticholinergic Drugs Segment Market Share, By Region 2012-2017
  • TABLE 27: Global Anticholinergic Drugs Segment Market Share, By Region 2018-2026
  • TABLE 28: Global Anticholinergic Drugs Segment Y-o-Y, By Region 2017-2026
  • TABLE 29: Global Desmopressin Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 30: Global Desmopressin Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 31: Global Desmopressin Segment Market Share, By Region 2012-2017
  • TABLE 32: Global Desmopressin Segment Market Share, By Region 2018-2026
  • TABLE 33: Global Desmopressin Segment Y-o-Y, By Region 2017-2026
  • TABLE 34: Global Antibiotics Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 35: Global Antibiotics Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 36: Global Antibiotics Segment Market Share, By Region 2012-2017
  • TABLE 37: Global Antibiotics Segment Market Share, By Region 2018-2026
  • TABLE 38: Global Antibiotics Segment Y-o-Y, By Region 2017-2026
  • TABLE 39: Global Antispasmodic Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 40: Global Antispasmodic Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 41: Global Antispasmodic Segment Market Share, By Region 2012-2017
  • TABLE 42: Global Antispasmodic Segment Market Share, By Region 2018-2026
  • TABLE 43: Global Antispasmodic Segment Y-o-Y, By Region 2017-2026
  • TABLE 44: Global Other Drugs Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 45: Global Other Drugs Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 46: Global Other Drugs Segment Market Share, By Region 2012-2017
  • TABLE 47: Global Other Drugs Segment Market Share, By Region 2018-2026
  • TABLE 48: Global Other Drugs Segment Y-o-Y, By Region 2017-2026
  • TABLE 49: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 50: Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 51: Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
  • TABLE 52: Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
  • TABLE 53: Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
  • TABLE 54: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 55: Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 56: Global Retail Pharmacies Segment Market Share, By Region 2012-2017
  • TABLE 57: Global Retail Pharmacies Segment Market Share, By Region 2018-2026
  • TABLE 58: Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
  • TABLE 59: Global Drug Stores Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 60: Global Drug Stores Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 61: Global Drug Stores Segment Market Share, By Region 2012-2017
  • TABLE 62: Global Drug Stores Segment Market Share, By Region 2018-2026
  • TABLE 63: Global Drug Stores Segment Y-o-Y, By Region 2017-2026
  • TABLE 64: Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
  • TABLE 65: Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
  • TABLE 66: Global Online Pharmacies Segment Market Share, By Region 2012-2017
  • TABLE 67: Global Online Pharmacies Segment Market Share, By Region 2018-2026
  • TABLE 68: Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
  • TABLE 69: North America Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 70: North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 71: North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 72: North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 73: North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 74: North America Nocturia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 75: North America Nocturia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 76: North America Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 77: North America Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 78: North America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 79: North America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 80: North America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 81: North America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
  • TABLE 82: Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 83: Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 84: Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 85: Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 86: Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 87: Latin America Nocturia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 88: Latin America Nocturia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 89: Latin America Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 90: Latin America Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 91: Latin America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 92: Latin America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 93: Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 94: Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
  • TABLE 95: Europe Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 96: Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 97: Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 98: Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 99: Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 100: Europe Nocturia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 101: Europe Nocturia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 102: Europe Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 103: Europe Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 104: Europe Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 105: Europe Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 106: Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 107: Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
  • TABLE 108: APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 109: APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 110: APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 111: APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 112: APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 113: APEJ Nocturia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 114: APEJ Nocturia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 115: APEJ Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 116: APEJ Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 117: APEJ Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 118: APEJ Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 119: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 120: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
  • TABLE 121: MEA Current Expenditure on Health, (% of GDP), by Country, 2010 - 2016
  • TABLE 122: MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
  • TABLE 123: MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
  • TABLE 124: MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
  • TABLE 125: MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
  • TABLE 126: MEA Nocturia Market Value (US$ Mn), By Country 2012-2017
  • TABLE 127: MEA Nocturia Market Value (US$ Mn), By Country 2018-2026
  • TABLE 128: MEA Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • TABLE 129: MEA Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • TABLE 130: MEA Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
  • TABLE 131: MEA Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • TABLE 132: MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • TABLE 133: MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026

List of Figures

  • FIG. 1: Global Nocturia Market Value (US$ Mn), 2012-2017
  • FIG. 2: Global Nocturia Market Value (US$ Mn) Forecast, 2018-2026
  • FIG. 3: Global Nocturia Market Value (US$ Mn) and Y-o-Y, 2017-2026
  • FIG. 4: Global Mixed Nocturia Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 5: Global Mixed Nocturia Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 6: Global Mixed Nocturia Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 7: Global Low Nocturnal Bladder Capacity Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 8: Global Low Nocturnal Bladder Capacity Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 9: Global Low Nocturnal Bladder Capacity Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 10: Global Nocturnal Polyuria Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 11: Global Nocturnal Polyuria Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 12: Global Nocturnal Polyuria Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 13: Global Polyuria Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 14: Global Polyuria Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 15: Global Polyuria Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 16: Global Anticholinergic Drugs Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 17: Global Anticholinergic Drugs Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 18: Global Anticholinergic Drugs Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 19: Global Desmopressin Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 20: Global Desmopressin Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 21: Global Desmopressin Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 22: Global Antibiotics Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 23: Global Antibiotics Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 24: Global Antibiotics Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 25: Global Antispasmodic Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 26: Global Antispasmodic Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 27: Global Antispasmodic Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 28: Global Other Drugs Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 29: Global Other Drugs Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 30: Global Other Drugs Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 31: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 32: Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 33: Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 34: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 35: Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 36: Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 37: Global Drug Stores Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 38: Global Drug Stores Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 39: Global Drug Stores Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 40: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
  • FIG. 41: Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
  • FIG. 42: Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
  • FIG. 43: North America Nocturia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 44: North America Nocturia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 45: North America Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 46: North America Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 47: North America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
  • FIG. 48: North America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 49: North America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 50: North America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
  • FIG. 51: Latin America Nocturia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 52: Latin America Nocturia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 53: Latin America Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 54: Latin America Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 55: Latin America Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
  • FIG. 56: Latin America Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 57: Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 58: Latin America Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
  • FIG. 59: Europe Nocturia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 60: Europe Nocturia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 61: Europe Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 62: Europe Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 63: Europe Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
  • FIG. 64: Europe Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 65: Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 66: Europe Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
  • FIG. 67: APEJ Nocturia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 68: APEJ Nocturia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 69: APEJ Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 70: APEJ Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 71: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 72: APEJ Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 73: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 74: APEJ Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
  • FIG. 75: MEA Nocturia Market Value (US$ Mn), By Country 2012-2017
  • FIG. 76: MEA Nocturia Market Value (US$ Mn), By Country 2018-2026
  • FIG. 77: MEA Nocturia Market Value (US$ Mn), By Indication 2012-2017
  • FIG. 78: MEA Nocturia Market Value (US$ Mn), By Indication 2018-2026
  • FIG. 79: MEA Nocturia Market Value (US$ Mn), By Drug Type 2012-2017
  • FIG. 80: MEA Nocturia Market Value (US$ Mn), By Drug Type 2018-2026
  • FIG. 81: MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2012-2017
  • FIG. 82: MEA Nocturia Market Value (US$ Mn), By Distribution Channel 2018-2026
Back to Top